Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
F	O
Service:	O
MEDICINE	O
Allergies:	O
Penicillins	O
Attending:	O
___.	O
Chief	O
Complaint:	O
Shortness	O
of	O
breath	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
None	O
History	O
of	O
Present	O
Illness:	O
___	O
yo	O
female	O
with	O
h/o	O
HTN,	O
GERD	O
and	O
arthritis	O
who	O
presents	O
with	O
episode	O
of	O
SOB	O
this	O
morning.	O
Patient	O
was	O
sitting	O
at	O
home	O
and	O
became	O
SOB,	O
denies	O
any	O
history	O
of	O
SOB.	O
Episode	O
this	O
morning	O
was	O
associated	O
with	O
Nausea.	O
She	O
denies	O
any	O
chest	O
pain,	O
palpitations,	O
radiating	O
pain,	O
diaphoresis.	O
She	O
decided	O
to	O
come	O
into	O
the	O
ED	O
as	O
she	O
did	O
not	O
feel	O
well.	O
She	O
reports	O
one	O
episode	O
of	O
small	O
emesis	O
in	O
the	O
ED.	O
Symtpoms	O
have	O
now	O
resolved.	O
She	O
denies	O
any	O
history	O
of	O
SOB	O
or	O
chest	O
pain.	O
She	O
has	O
stairs	O
at	O
home	O
and	O
denies	O
CP	O
or	O
SOB	O
with	O
stairs.	O
She	O
reports	O
a	O
normal	O
stress	O
test	O
6	O
months	O
ago.	O
On	O
further	O
questioning,	O
she	O
does	O
report	O
+white	O
sputum	O
production	O
for	O
2	O
weeks	O
which	O
is	O
associated	O
with	O
nasal	O
congestion.	O
She	O
denies	O
cough,	O
fevers,	O
chills,	O
abdominal	O
pain,	O
or	O
diarrhea.	O
She	O
does	O
report	O
sick	O
contacts	O
recently	O
with	O
some	O
guests	O
who	O
had	O
a	O
'cold'.	O
She	O
was	O
seen	O
by	O
her	O
PCP	O
for	O
her	O
'sputum	O
production'	O
who	O
prescribed	O
fluticasone,	O
tussin	O
and	O
Allegra	O
for	O
treatment	O
of	O
these	O
symptoms.	O
In	O
ED,	O
afebrile,	O
VSS.	O
No	O
elevated	O
in	O
WBC.	O
LFTs	O
wnl.	O
U/A	O
negative,	O
D-dimer	O
886,	O
CTA	O
negative	O
for	O
PE.	O
CXR	B-Lower_respiratory_tract_infection
wnl.	B-Lower_respiratory_tract_infection
EKG	O
with	O
no	O
acute	O
ST/T	O
changes	O
and	O
CE	O
negative	O
x2.	O
Pt	O
given	O
famotidine,	O
zofran	O
in	O
ED	O
for	O
nausea.	O
Also	O
received	O
1	O
dose	O
of	O
Levofloxacin	O
for	O
pneumonia	B-Lower_respiratory_tract_infection
as	O
CT	O
showed	O
a	O
small	O
focus	O
of	O
infection	B-Lower_respiratory_tract_infection
or	O
inflammation	O
in	O
RUL.	B-Lower_respiratory_tract_infection
Past	O
Medical	O
History:	O
PMH:	O
HTN	O
GERD	O
Arthritis	O
h/o	O
hypokalemia	O
Social	O
History:	O
___	O
Family	O
History:	O
Mother	O
with	O
stroke	O
in	O
her	O
___,	O
sister	O
with	O
stroke	O
also	O
in	O
old	O
___.	O
No	O
seizures,	B-Seizures
migraines,	O
DM,	O
MI,	O
cancer.	O
Physical	O
Exam:	O
T	O
98.8	O
BP	O
166/70	O
HR	O
84	O
RR	O
20	O
O2	O
sat	O
99%	O
2LNC	O
Gen	O
-	O
NAD,	O
lying	O
comfortably	O
in	O
bed,	O
HEENT	O
-	O
PERRLA,	O
EOMI,	O
MMM,	O
NCAT	O
Neck	O
-	O
No	O
LAD,	O
no	O
JVD	O
CV	O
-	O
+S1,	O
+S2,	O
no	O
M/R/G,	O
RRR	O
Lungs	O
-	O
CTAB,	O
no	O
wheezes,	O
crackles	O
or	O
ronchi	O
Abd	O
-	O
+BS,	O
NT/ND,	O
no	O
hsm	O
Ext	O
-	O
no	O
C/C/E,	O
+2	O
distal	O
pulses	O
Neuro	O
-	O
CN	O
II-XII	O
intact,	O
moving	O
all	O
extremities	O
voluntarily	O
Pertinent	O
Results:	O
___	O
04:30AM	O
BLOOD	O
WBC-9.8	O
RBC-3.88*	O
Hgb-12.2	O
Hct-35.5*	O
MCV-92	O
MCH-31.5	O
MCHC-34.4	O
RDW-12.6	O
Plt	O
___	O
___	O
07:35AM	O
BLOOD	O
WBC-10.7	O
RBC-3.73*	O
Hgb-11.6*	O
Hct-34.8*	O
MCV-93	O
MCH-31.1	O
MCHC-33.4	O
RDW-12.8	O
Plt	O
___	O
___	O
08:50AM	O
BLOOD	O
D-Dimer-886*	O
___	O
04:30AM	O
BLOOD	O
Glucose-108*	O
UreaN-21*	O
Creat-1.0	O
Na-135	O
K-3.6	O
Cl-95*	O
HCO3-23	O
AnGap-21*	O
___	O
07:35AM	O
BLOOD	O
Glucose-95	O
UreaN-15	O
Creat-1.1	O
Na-139	O
K-3.6	O
Cl-100	O
HCO3-29	O
AnGap-14	O
___	O
04:30AM	O
BLOOD	O
ALT-19	O
AST-30	O
CK(CPK)-56	O
AlkPhos-99	O
TotBili-0.2	O
___	O
12:35PM	O
BLOOD	O
CK(CPK)-53	O
___	O
10:05PM	O
BLOOD	O
CK(CPK)-90	O
___	O
04:30AM	O
BLOOD	O
CK-MB-NotDone	O
cTropnT-<0.01	O
___	O
12:35PM	O
BLOOD	O
CK-MB-NotDone	O
cTropnT-<0.01	O
___	O
10:05PM	O
BLOOD	O
CK-MB-4	O
cTropnT-<0.01	O
Micro:	O
Influenza	O
DFA	O
negative	O
STUDIES:	O
EKG	O
-	O
NSR	O
@	O
77	O
bpm,	O
nl	O
axis,	O
nl	O
intervals,	O
no	O
ST	O
elevations	O
or	O
depressions,	O
no	O
TWI,	O
poor	O
R	O
wave	O
progression.	O
Unchanged	O
from	O
prior	O
on	O
___.	O
CXR	O
-	O
The	O
heart	O
size	O
and	O
mediastinal	O
contours	O
are	O
stable	O
and	O
within	O
normal	O
limits.	O
The	O
lungs	O
are	O
grossly	O
clear	O
without	O
evidence	O
of	O
consolidation.	O
Stable	O
mild	O
leftward	O
tracheal	O
deviation	O
is	O
likely	O
caused	O
by	O
goiter,	O
unchanged.	O
There	O
is	O
no	O
subdiaphragmatic	O
free	O
air.	O
IMPRESSION:	O
No	O
acute	O
intrathoracic	B-Lower_respiratory_tract_infection
process.	B-Lower_respiratory_tract_infection
CTA	O
chest	O
-	O
No	O
PE.	O
Moderate	O
atheroma	O
within	O
aortic	O
arch	O
and	O
descending	O
aorta.	O
Small	O
focus	O
of	O
infection	O
or	O
inflammation	O
in	O
RUL.	O
Brief	O
Hospital	O
Course:	O
___	O
yo	O
female	O
with	O
h/o	O
HTN,	O
GERD	O
and	O
arthritis	O
who	O
presents	O
with	O
episode	O
of	O
SOB	O
this	O
morning	O
associated	O
with	O
Nausea.	O
#Nausea-	O
Likely	O
related	O
to	O
GERD;	O
patient	O
had	O
gastric	O
emptying	O
study	O
___	O
which	O
showed	O
slowed	O
gastric	O
emptying	O
time	O
(followed	O
by	O
GI	O
as	O
outpt).	O
Patient	O
has	O
no	O
history	O
of	O
CAD,	O
but	O
concern	O
was	O
that	O
nausea	O
could	O
be	O
cardiac	O
in	O
nature.	O
She	O
was	O
admitted	O
and	O
ruled	O
out	O
for	O
myocardial	O
infarction	O
with	O
Cardiac	O
enzymes	O
negative	O
x	O
3.	O
Her	O
Nausea	O
and	O
Vomiting	O
resolved	O
and	O
she	O
was	O
discharged	O
home	O
with	O
follow	O
up	O
with	O
her	O
PCP.	O
She	O
was	O
continued	O
on	O
her	O
home	O
Reglan,	O
PPI	O
and	O
Ranitidine.	O
She	O
was	O
told	O
to	O
use	O
Maalox	O
as	O
needed.	O
___-	O
Ms.	O
___	O
has	O
no	O
history	O
of	O
CAD.	O
She	O
had	O
a	O
normal	O
pMIBI	O
in	O
___.	O
Current	O
symptoms	O
were	O
thought	O
to	O
be	O
unlikely	O
___	O
to	O
MI.	O
She	O
was	O
ruled	O
out	O
for	O
Myocardial	O
Infarction	O
as	O
above.	O
#URI-	O
Patient	O
reports	O
sputum	O
production	O
assoicated	O
with	O
nasal	O
congestion	O
x	O
2	O
weeks.	O
Likely	O
___	O
URI.	O
She	O
has	O
ruled	O
out	O
for	O
flu,	O
and	O
is	O
afebrile.	O
She	O
is	O
to	O
continue	O
her	O
home	O
fluticasone,	O
allegra,	O
and	O
tussin.	O
#HTN-Continue	O
Norvasc,	O
HCTZ	O
Medications	O
on	O
Admission:	O
HCTZ	O
12.5mg	O
daily	O
Norvasc	O
2.5mg	O
daily	O
Potassium	O
20mEq	O
daily	O
asa	O
81mg	O
daily	O
MVI	O
Nexium	O
40mg	O
BID	O
Allegra	O
Tussin	O
Fluticasone	O
Discharge	O
Medications:	O
1.	O
Nexium	O
40	O
mg	O
Capsule,	O
Delayed	O
Release(E.C.)	O
Sig:	O
One	O
(1)	O
Capsule,	O
Delayed	O
Release(E.C.)	O
PO	O
twice	O
a	O
day.	O
2.	O
Potassium	O
Chloride	O
20	O
mEq	O
Packet	O
Sig:	O
One	O
(1)	O
PO	O
once	O
a	O
day.	O
3.	O
Ranitidine	O
HCl	O
150	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
DAILY	O
(Daily).	O
4.	O
Mylanta	O
311-232	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
once	O
a	O
day.	O
5.	O
Amlodipine	O
2.5	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
DAILY	O
(Daily).	O
6.	O
Hydrochlorothiazide	O
12.5	O
mg	O
Capsule	O
Sig:	O
One	O
(1)	O
Capsule	O
PO	O
DAILY	O
(Daily).	O
7.	O
Aspirin	O
81	O
mg	O
Tablet,	O
Chewable	O
Sig:	O
One	O
(1)	O
Tablet,	O
Chewable	O
PO	O
DAILY	O
(Daily).	O
8.	O
Hexavitamin	O
Tablet	O
Sig:	O
One	O
(1)	O
Cap	O
PO	O
DAILY	O
(Daily).	O
9.	O
Os-Cal	O
500	O
+	O
D	O
Oral	O
10.	O
Fexofenadine	O
60	O
mg	O
Tablet	O
Sig:	O
One	O
(1)	O
Tablet	O
PO	O
BID	O
(2	O
times	O
a	O
day).	O
11.	O
Fluticasone	O
50	O
mcg/Actuation	O
Spray,	O
Suspension	O
Sig:	O
___	O
Sprays	O
Nasal	O
DAILY	O
(Daily).	O
12.	O
Tussin	O
Oral	O
Discharge	O
Disposition:	O
Home	O
Discharge	O
Diagnosis:	O
Shortness	O
of	O
breath	O
Discharge	O
Condition:	O
Stable,	O
97%	O
ambulatory	O
oxygen	O
saturation,	O
improved	O
overall.	O
Tolerating	O
diet.	O
Discharge	O
Instructions:	O
You	O
were	O
admitted	O
into	O
the	O
hospital	O
for	O
evaluation	O
of	O
your	O
shortness	O
of	O
breath	O
and	O
nausea.	O
You	O
did	O
not	O
have	O
a	O
heart	O
attack.	O
A	O
Chest	O
X-ray	O
was	O
done	O
and	O
was	O
normal.	O
Your	O
symptoms	O
may	O
be	O
related	O
to	O
GERD.	O
You	O
are	O
to	O
continue	O
on	O
your	O
regular	O
GERD	O
medications.	O
Please	O
continue	O
with	O
your	O
regular	O
medications	O
as	O
instructed.	O
If	O
you	O
experience	O
worsening	O
shortness	O
of	O
breath,	O
chest	O
pain,	O
fevers,	O
chills,	O
nausea,	O
vomiting,	O
diarrhea	O
or	O
any	O
other	O
concerning	O
symptoms	O
then	O
please	O
call	O
your	O
doctor	O
or	O
report	O
to	O
the	O
nearest	O
emergency	O
room.	O
Followup	O
Instructions:	O
___	O

